Additionally, increased level of signaling molecules IRF-3 and TBK1 observed in the Berb-treated group indicate activation of the IRF-3-TBK-1 pathway, enhancing the expression of IFN-β, IFITM, and OAS1g, which are crucial in combating viral infections.42 This evidence concerns the gene TBK1 and viral infectious disease.